Cargando…

Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis

BACKGROUND: Pulmonary endothelial injury and microcirculatory thromboses likely contribute to hypoxemic respiratory failure, the most common cause of death, in patients with COVID‐19. Randomized controlled trials (RCTs) suggest differences in the effect of therapeutic heparin between moderately and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sholzberg, Michelle, da Costa, Bruno R., Tang, Grace H., Rahhal, Hassan, AlHamzah, Musaad, Baumann Kreuziger, Lisa, Ní Áinle, Fionnuala, Almarshoodi, Mozah Obaid, James, Paula D., Lillicrap, David, Carrier, Marc, Beckett, Andrew, Fralick, Michael, Middeldorp, Saskia, Lee, Agnes Y. Y., Thorpe, Kevin E., Negri, Elnara Márcia, Cushman, Mary, Jüni, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681879/ https://www.ncbi.nlm.nih.gov/pubmed/34977448 http://dx.doi.org/10.1002/rth2.12638

Ejemplares similares

Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG – RAPID Trial): A structured summary of a study protocol for a randomised controlled trial
por: Sholzberg, Michelle, et al.
Publicado: (2021)

Anticoagulation in hospitalized patients with COVID-19
por: Baumann Kreuziger, Lisa, et al.
Publicado: (2022)

A technical guide to supraclavicular thoracic outlet decompression
por: Hussain, Mohamad A., et al.
Publicado: (2021)

Rare Coexistence of Acute Intermittent Porphyria With Systemic Lupus Erythematous: Case Report and Literature Review
por: Yusuf, Asmaa, et al.
Publicado: (2023)

Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis?
por: Kevane, Barry, et al.
Publicado: (2017)

Thrombo‐inflammatory biomarkers and D‐dimer in a biracial cohort study
por: Kamin Mukaz, Debora, et al.
Publicado: (2021)

Anticoagulation as a therapeutic strategy for hospitalised patients with COVID-19
por: Cullivan, S., et al.
Publicado: (2022)

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
por: Sholzberg, Michelle, et al.
Publicado: (2021)

International normalized ratio and activated partial thromboplastin time testing
por: Chornenki, Nicholas L. J., et al.
Publicado: (2022)

Tests de dépistage du rapport international normalisé et du temps de céphaline activée
por: Chornenki, Nicholas L.J., et al.
Publicado: (2022)

Anticoagulation practice patterns in COVID‐19: A global survey
por: Rosovsky, Rachel P., et al.
Publicado: (2020)

VTE risk assessment in pregnancy
por: Ewins, Karl, et al.
Publicado: (2019)

Risk factors, diagnosis and management of venous thromboembolic disease in pregnancy
por: Edebiri, Osasere, et al.
Publicado: (2022)

Standardizing definitions for bleeding events in studies including pregnant women: A call to action
por: Saeed, Khalid, et al.
Publicado: (2022)

Heparin Therapy Improving Hypoxia in COVID-19 Patients – A Case Series
por: Negri, Elnara Marcia, et al.
Publicado: (2020)

Heparin – Messias or Verschlimmbesserung?
por: Swan, Dawn, et al.
Publicado: (2021)

Evaluating hemostatic thresholds for neuraxial anesthesia in adults with hemorrhagic disorders and tendencies: A scoping review
por: Peterson, Wynn, et al.
Publicado: (2021)

Response to: “Are women equal? Considering impact of therapeutic abortion bans on science”
por: Áinle, Fionnuala Ní, et al.
Publicado: (2022)

Diabetic foot and peripheral arterial disease: Single centre experience
por: Altoijry, Abdulmajeed, et al.
Publicado: (2021)

Preeclampsia and Venous Thromboembolism: Pathophysiology and Potential Therapy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

Desmopressin responsiveness by age in type 1 von Willebrand disease
por: Goldberg, Nicola, et al.
Publicado: (2020)

Vascular thoracic outlet syndrome: Registry of 30-years of patient’s outcomes at King Saud University Medical City, Riyadh, Saudi Arabia
por: Altoijry, Abdulmajeed, et al.
Publicado: (2022)

The Journey to a Successful Illustrated Review
por: Nersesian, Sarah, et al.
Publicado: (2022)

Management of cancer‐associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement
por: Held, Nicole, et al.
Publicado: (2022)

REDucing Unnecessary Coagulation Testing in the Emergency Department (REDUCED)
por: Fralick, Michael, et al.
Publicado: (2017)

Use of recombinant human antithrombin concentrate in pregnancy
por: Kreuziger, Lisa M Baumann, et al.
Publicado: (2013)

SARS-CoV-2 receptor binding domain-specific antibodies activate platelets with features resembling the pathogenic antibodies in heparin-induced thrombocytopenia
por: Zhu, Wen, et al.
Publicado: (2021)

Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports
por: Murphy, Niamh C, et al.
Publicado: (2014)

Incidence and Factors Associated with Uncontrolled Hypertension at 12 months after Kidney Transplantation in Saudi Arabia
por: Arabi, Ziad, et al.
Publicado: (2023)

P1666: THE BURDEN OF VENOUS THROMBOEMBOLISM AND THE CHALLENGES IN DELIVERING ADEQUATE CARE IN THE SETTING OF POVERTY, HOMELESSNESS, AND SOCIAL EXCLUSION: A SINGLE CENTRE CROSS-SECTIONAL STUDY
por: O’rourke, Ellen, et al.
Publicado: (2023)

Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study
por: Woodruff, Seth, et al.
Publicado: (2019)

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2023)

Heparin-induced Anaphylaxis shock
por: Mohamed, Anas, et al.
Publicado: (2023)

POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes
por: Tritschler, Tobias, et al.
Publicado: (2022)

Liver stiffness and thrombin generation in compensated cirrhosis
por: Dillon, Audrey, et al.
Publicado: (2019)

Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
por: Baumann Kreuziger, Lisa M., et al.
Publicado: (2014)

Complications of Silicone Fillers in Gluteal Augmentation: An Unusual Case of Filler Migration and Granuloma Formation
por: Mortada, Hatan, et al.
Publicado: (2023)

Heparines
por: de Graaf, Linda
Publicado: (2022)

Heparin: Heparin-induced thrombocytopenia: case report
Publicado: (2020)

Heparin: Heparin-induced thrombocytopenia : case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m52jsm5dlot3fhva0fhca20u43